PMID: 9187994Jun 1, 1997Paper

Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension

Journal of Cardiothoracic and Vascular Anesthesia
T HachenbergT Brüssel

Abstract

To compare the cardiovascular and pulmonary effects of the phosphodiesterase III inhibitor enoximone (EN) or a combination of dobutamine (DOB) and nitroglycerin (NTG) before and after mitral valve repair or replacement. Prospective, randomized, controlled clinical study. University hospital. Twenty patients with mitral regurgitation and pulmonary venous hypertension scheduled for elective mitral valve surgery. Patients fulfilling the inclusion criteria of the study were randomly allocated into a group treated with EN (group 1, n = 10) or DOB and NTG (group 2, n = 10). A cardiopulmonary status was obtained after induction of anesthesia and mechanical ventilation during stable hemodynamic conditions (control). Then the patients received either EN (bolus dose 1.0 mg/kg followed by a continuous infusion of 10 micrograms/kg/min) or DOB (8.0 micrograms/kg/min) and NTG (1.0 microgram/kg/min) according to the randomization. After a period of 20 minutes, all parameters were measured again. The study drugs were stopped, and cardiac surgery was performed. Infusions of EN (without additional loading dose) or DOB and NTG were started again in the above-described doses 10 minutes before separation from cardiopulmonary bypass (CPB). Respirato...Continue Reading

References

Dec 11, 1991·Anesthesiology·J M BaileyC C Hug
Jul 1, 1988·The American Journal of Cardiology·C V LeierD V Unverferth
Apr 1, 1989·Anesthesia and Analgesia·K J Schwenzer, E D Miller
Feb 1, 1987·Journal of Cardiothoracic Anesthesia·H I RutmanE H Sonnenblick
Jan 1, 1985·The American Journal of Cardiology·M McGregor, A Sniderman
Oct 1, 1982·Acta Anaesthesiologica Scandinavica·E Anjou-LindskogA Holmgren
Mar 1, 1994·Anesthesiology·T HachenbergG Hedenstierna
Jan 1, 1993·Chest·Y LouagieJ C Schoevaerdts
Mar 1, 1993·Current Opinion in Cardiology·J P Johns, R J Bryg

❮ Previous
Next ❯

Citations

Oct 3, 2006·Current Opinion in Anaesthesiology·J UrzuaC Saez
Nov 5, 1999·Journal of Cardiovascular Pharmacology·J L CracowskiP Devillier
Jul 1, 2005·Critical Care : the Official Journal of the Critical Care Forum·Michael GilliesBrian Buxton
Sep 23, 2010·Critical Care : the Official Journal of the Critical Care Forum·Laura C PriceStephen J Brett
May 23, 2003·Anesthesia and Analgesia·Lars G FischerHartmut Bu Combining Diaeresis Rkle
Mar 27, 2012·Medicina intensiva·J L Pérez VelaUNKNOWN Grupo de Trabajo de Cuidados Intensivos Cardiológicos y RCP de SEMICYUC, con el aval científico de la SEMICYUC
Mar 7, 2007·Clinics in Chest Medicine·James R Klinger
Feb 6, 2015·British Journal of Anaesthesia·T GrecoA Zangrillo
May 31, 2007·Seminars in Cardiothoracic and Vascular Anesthesia·Kathirvel Subramaniam, Jean-Pierre Yared

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.